Literature DB >> 6227114

Genetic control and effector cells in host-versus-graft responses to H-Y antigen in mice.

D Pole, E Simpson.   

Abstract

T cell responses to the male-specific H-Y antigen in mice include skin graft rejection, delayed-type hypersensitivity and cytotoxic T cell responses; these are under complex H-2 and non-H-2 Ir gene control. The effector cells for these two in vivo responses are Ly 1+2-, and the cytotoxic T cell effectors generated in secondary mixed lymphocyte reactions in vitro are Ly1+2+, although their development requires the presence of Ly 1+2- T helper cells. We investigated the Ir gene control of another in vivo response to H-Y, the host-versus-graft response (HVGR), measured by popliteal lymph node enlargement. The strain distribution pattern (SDP) of primary and secondary HVG responses to H-Y indicates that there are both H-2 and non-H-2 Ir genes involved in controlling responsiveness. Cell transfer of the secondary response identifies an Ly 1+2- effector T cell for this response: this information together with the SDP of cytotoxic T cell responses suggests that the HVGR may represent activation of the T helper population involved in the generation of cytotoxic T cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6227114     DOI: 10.1097/00007890-198311000-00014

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  Influence of the combination of intraperitoneal and footpad immunization on anti-H-Y immunological reactivity.

Authors:  A Juretić
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

2.  B-cell responses to male-specific antigen(s) in mice.

Authors:  R J Hancock; D W Dresser
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

3.  Delayed-type hypersensitivity to allogeneic mouse epidermal cell antigens. I. Lyt-1+2- T cells are important for DTH.

Authors:  N Ishii; H Nakajima; I Aoki; T Ishii; T Takahashi; K Okuda
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.